Preparing a submission for Drugs in R&D
Drugs in R&D sets its own submission rules: length and word limits, the required citation and reference style, figure and table formatting, and editorial policies. Scraiber tracks 21 requirements for Drugs in R&D and rewrites your manuscript to meet each one.
Instead of checking each rule by hand, import your draft into Scraiber, select Drugs in R&D, and let it rewrite your text to match: the exact word limits, reference style and structure, so your paper is submission-ready.
If the paper was rejected elsewhere, most of the work in retargeting Drugs in R&D is mechanical: the reference style changes, headings and sections move, word and abstract limits differ, and the declarations have to follow Drugs in R&D's own template. Scraiber applies those changes to the draft you already have instead of you rebuilding the manuscript by hand.
Manuscript types at Drugs in R&D
Drugs in R&D documents its author requirements per manuscript type: Case Report, Current Opinion, Editorial/Commentary, Leading Article, Letter to the Editor, Original research, Review Article, Systematic Review. The rules differ between them, so Scraiber applies the set that matches the type you are submitting.
What Drugs in R&D specifies
These are the areas Drugs in R&D writes rules for. Scraiber holds the exact value behind each one and applies it to your draft.
- Length & word limits 2 rules: abstract word limit, word limit.
- Citations & references 1 rule: citation style.
- Formatting & submission 8 rules: abbreviation rules, competing interests, contributor roles, cover letter, data availability, ethics statement, in text citation format, units.
What Scraiber changes in your manuscript
Scraiber rewrites the parts of your draft that Drugs in R&D constrains: it brings sections within the required lengths, converts in-text citations and the bibliography to the required style, adjusts headings and structure, and flags the declarations Drugs in R&D expects. Your argument, results and voice stay yours — only what the journal dictates changes.
Frequently asked questions
- What are the submission requirements for Drugs in R&D?
- Drugs in R&D has 21 documented author requirements covering length limits, citation style, figures, tables and submission policies. Sign in to Scraiber to see each exact value and rewrite your manuscript to match.
- Which citation style does Drugs in R&D use?
- Scraiber tracks Drugs in R&D's required reference style and reformats your citations to it automatically. Open the journal in Scraiber to apply it to your document.
- Can I automatically format my paper for Drugs in R&D?
- Yes. Paste or import your draft into Scraiber, pick Drugs in R&D, and it rewrites your text to meet the journal's requirements: length, references, structure and more.
- How do I reformat a paper rejected by another journal for Drugs in R&D?
- Import the manuscript you already submitted elsewhere, select Drugs in R&D, and Scraiber rewrites it against Drugs in R&D's requirements: reference style, length limits, structure and declarations. You never start from a blank page.
- How long does it take to prepare a manuscript for Drugs in R&D?
- Minutes rather than an evening. The rewrite runs on your existing draft, so what disappears is the manual pass over every formatting rule.
- Does Drugs in R&D have different requirements per manuscript type?
- Yes. Drugs in R&D documents separate requirements per manuscript type. Pick your type in Scraiber and it applies that set to your document.
- Do I have to redo my references for Drugs in R&D?
- No. Scraiber converts your existing citations and bibliography to the reference style Drugs in R&D requires, including the in-text citation format.
Official author guidelines: link.springer.com